Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by H. Lee Moffitt Cancer Center and Research Institute
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT01286038
First received: January 27, 2011
Last updated: September 10, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)